Patents by Inventor Cecilia Lindestam Arlehamn

Cecilia Lindestam Arlehamn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • T CELL TRANSCRIPTOMIC PROFILES IN PARKINSON'S DISEASE, AND METHODS AND USES THEREOF
    Publication number: 20240263237
    Abstract: This disclosure provides methods for determining whether a subject is suffering from a neurodegenerative disease, and/or methods of treating a neurodegenerative disease. The disclosed methods comprise detecting differential expression one or more genes or gene products from a sample obtained from the subject.
    Type: Application
    Filed: May 27, 2022
    Publication date: August 8, 2024
    Applicant: La Jolla Institute for Immunology
    Inventors: Alessandro Sette, Cecilia Lindestam Arlehamn
  • USE OF PEPTIDES AS BIOMARKERS IN THE DIAGNOSIS, CONFIRMATION AND TREATMENT OF A NEUROLOGICAL DISORDER AND TCR AND/OR HLA IMMUNOPROFILING IN NEURODEGENERATIVE DISEASE
    Publication number: 20200095296
    Abstract: The present invention provides methods for assessing whether a subject is at risk of developing a neurological disorder, diagnosing or confirming whether a subject is afflicted with a neurological disorder, assessing a neurological disorder is developing in a subject who has been identified as being at risk of developing the neurological disorder, assessing whether a subject afflicted with a neurological disorder is likely to benefit iron a therapy, assessing whether a subject afflicted with a neurological disorder has benefited from a therapy, treating a subject afflicted with a neurological disorder, and prophylactically treating a subject who has been identified as being at risk, of developing a neurological disorder. The present invention also provides epitopes, compounds and compositions relating to these methods.
    Type: Application
    Filed: June 4, 2018
    Publication date: March 26, 2020
    Applicants: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, LA JOLLA INSTITUTE FOR ALLERGY & IMMUNOLOGY, THE RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC.
    Inventors: David Sulzer, Alessandro Sette, Cecilia Lindestam Arlehamn, John Pham, Bjoern Peters
  • Specific and unique T cell responses and molecular signatures for the treatment and diagnosis of
    Patent number: 10406218
    Abstract: The invention relates to novel targets for immune response modulation, treatment of tuberculosis infection and epitopes of Mycobacterium tuberculosis, or subsequences, portions or modifications thereof, and methods and compounds for treatment and prevention of tuberculosis infection.
    Type: Grant
    Filed: April 9, 2015
    Date of Patent: September 10, 2019
    Assignee: LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY
    Inventors: Alessandro Sette, Bjoern Peters, Cecilia Lindestam Arlehamn, Greg Seumois, Pandurangan Vijayanand, Sonia Sharma
  • SPECIFIC AND UNIQUE T CELL RESPONSES AND MOLECULAR SIGNATURES FOR THE TREATMENT AND DIAGNOSIS OF MYCOBACTERIUM TUBERCULOSIS
    Publication number: 20170028049
    Abstract: The invention relates to novel targets for immune response modulation, treatment of tuberculosis infection and epitopes of Mycobacterium tuberculosis, or subsequences, portions or modifications thereof, and methods and compounds for treatment and prevention of tuberculosis infection.
    Type: Application
    Filed: April 9, 2015
    Publication date: February 2, 2017
    Inventors: Alessandro Sette, Bjoern Peters, Cecilia Lindestam Arlehamn, Greg Seumois, Pandurangan Vijayanand